Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial
Go back to Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.82 -0.03 (3.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.85 | 52 Week High | $1.37 | |||
| Open | $0.83 | 52 Week Low | $0.24 | |||
| Day High | $0.84 | P/E | N/A | |||
| Day Low | $0.81 | EPS | $0.00 | |||
| Volume | 703,370 | |||||
